MAFM
NVAX icon

Mid Atlantic Financial Management’s Novavax NVAX Stock Holding History

Mid Atlantic Financial Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$254K Buy
1,225
+200
+20% +$44.1K 0.02% 730
2021
Q2 		$218K Sell
1,025
-85
-8% -$15.6K 0.01% 805
2021
Q1 		$201K Buy
+1,110
New +$221K 0.01% 773

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mid Atlantic Financial Management's NVAX Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its Novavax (NVAX) stake by 20% in Q3 2021, buying an estimated $44.1K and bringing the position to 1,225 shares worth $254K. The position accounts for 0.02% of the portfolio, ranked #730.

Mid Atlantic Financial Management first reported a position in NVAX in Q1 2021 and has held it in 3 quarters since. 443 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

  • Mid Atlantic Financial Management held 1,225 shares of Novavax worth $254K as of Q3 2021.
  • Mid Atlantic Financial Management bought 200 Novavax shares in Q3 2021, an estimated $44.1K.
  • Novavax made up 0.02% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #730 holding.
  • Mid Atlantic Financial Management first reported a position in Novavax in Q1 2021 and has held it in 3 quarters since.
  • 443 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.